|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03869 HOSPITAL CORP
Nominal 
4.800 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 719,503 | 0.233% | 1,427,733 | 1,142,951 | 520,290 | 399,214 |
| Cost of Sales | (566,879) | -5.153% | (1,188,373) | (992,073) | (306,063) | (204,885) |
| Gross Profit | 152,624 | 27.025% | 239,360 | 150,878 | 214,227 | 194,329 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | 884 | (462,150) | (578,458) | (683,296) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 61,445 | -69.426% | 216,204 | (532,628) | (449,102) | (435,823) | |
| Taxation | (35,948) | 55.916% | (47,860) | 4,031 | 86,706 | 14,754 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (44,215) | -14.474% | (36,960) | 47,649 | 81,687 | 16,727 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (18,718) | -- | 131,384 | (480,948) | (280,709) | (404,342) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 52,360 | -- | (1,706) | (5,360) | 14,028 | 35,982 |
| Depreciation & Amortisation | 31,447 | -4.712% | 62,862 | 63,279 | 41,145 | 42,902 |
| Directors' Emoluments | -- | -- | 2,262 | 6,389 | 5,069 | 11,145 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified (Modified Report) | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -14.000 | -- | 95.600 | -348.000 | -203.100 | -292.600 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.602 | 1.036 | 0.963 | 0.604 |
| NBV per share ($) | 2.608 | -- | 2.743 | 1.850 | 5.774 | 7.816 |
| Remarks: | Real time quote last updated: 18/11/2024 13:11 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -18,718,000 |
| %Change | -- |
| EPS / (LPS) | RMB -0.140 |
| NBV Per Share (¥) | RMB 2.608 |